Clinical spectrum of extreme insulin resistance syndromes treated with rhIGF-1: A single-center experience

• by Nicola Improda, Harshini Katugampola, Manuela Cerbone, Pratik Shah, Saji Alexander, Abigail Atterbury, Smail Hadj-Rabia, Catherine J Peters, Robert K Semple, Mehul Tulsidas Dattani

• January 28, 2026

A clinically interpretable machine learning model for early detection of diabetic retinopathy in multiple community health centers

• by Juncheng Tong, Aifa Tang, Lifang Liu, Luyuan Zhang, Hainan Wang, Mengyuan Qu, Bing Liu

• May 4, 2026

Keeping an Eye on Diabetes

Progress, pitfalls and the future of the UK’s Diabetic Eye Screening Program

• by Devansh Tandon

• April 28, 2026

• 7 min

Neo or Not Neo? Widefield OCT-A Reveals Hidden Neovascularization

Utilizing OCT and OCT-A technologies revealed critical insights into a patient’s complex retinopathy, as highlighted by Dr. Julie Rodman.

• by Julie Rodman, OD, MSc, FAAO

• March 2, 2026

• 3 min